DK0460190T3 - Fremgangsmåde til påvisning af maligne sygdomme - Google Patents

Fremgangsmåde til påvisning af maligne sygdomme

Info

Publication number
DK0460190T3
DK0460190T3 DK91902191.5T DK91902191T DK0460190T3 DK 0460190 T3 DK0460190 T3 DK 0460190T3 DK 91902191 T DK91902191 T DK 91902191T DK 0460190 T3 DK0460190 T3 DK 0460190T3
Authority
DK
Denmark
Prior art keywords
pct
receptors
malignant diseases
date jul
sample
Prior art date
Application number
DK91902191.5T
Other languages
English (en)
Inventor
Heinz Bodenmueller
Andreas Dessauer
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6396458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0460190(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of DK0460190T3 publication Critical patent/DK0460190T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
DK91902191.5T 1989-12-27 1990-12-27 Fremgangsmåde til påvisning af maligne sygdomme DK0460190T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3942999A DE3942999C2 (de) 1989-12-27 1989-12-27 Verfahren zum Nachweis von malignen Erkrankungen

Publications (1)

Publication Number Publication Date
DK0460190T3 true DK0460190T3 (da) 1995-08-28

Family

ID=6396458

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902191.5T DK0460190T3 (da) 1989-12-27 1990-12-27 Fremgangsmåde til påvisning af maligne sygdomme

Country Status (9)

Country Link
US (1) US5288614A (da)
EP (1) EP0460190B2 (da)
JP (1) JPH082919B2 (da)
AT (1) ATE120550T1 (da)
CA (1) CA2046888A1 (da)
DE (2) DE3942999C2 (da)
DK (1) DK0460190T3 (da)
ES (1) ES2070488T5 (da)
WO (1) WO1991010139A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4208422A1 (de) * 1992-03-16 1993-09-30 Boehringer Mannheim Gmbh Verfahren zum Nachweis von Mikrometastasen ekto- oder entodermaler Tumoren
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
US6207380B1 (en) 1997-09-15 2001-03-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
DE19855819C2 (de) * 1998-12-03 2001-02-15 Roche Diagnostics Gmbh Stabilisierung von Cytokeratin enthaltenden Kalibratoren
US8980568B2 (en) * 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
WO2005043166A1 (ja) * 2003-10-30 2005-05-12 Sysmex Corporation 子宮腺癌の診断薬及び腺癌細胞の検出方法
EP3147665A1 (en) * 2005-12-22 2017-03-29 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
CA2657621A1 (en) * 2006-07-14 2008-01-17 Aviva Biosciences Corporation Methods and compositions for detecting rare cells from a biological sample
EP2064552B1 (en) * 2006-09-07 2011-08-31 Universitätsklinikum Hamburg-Eppendorf Method for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells
CN103476428B (zh) * 2010-09-09 2016-10-26 北京同为时代生物技术有限公司 用于诊断上皮源性癌症的血液标志物及其单克隆抗体
SG11201408651TA (en) 2012-06-27 2015-01-29 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
CN106061998B (zh) * 2014-02-05 2020-12-11 弗吉瑞必欧诊断股份公司 用于检测恶性赘生性疾病的组合物和方法
KR102657306B1 (ko) 2014-12-08 2024-04-12 버그 엘엘씨 전립선암의 진단 및 치료에서 필라민을 포함하는 마커의 용도
JP6637290B2 (ja) * 2015-11-05 2020-01-29 武 永安 Ｃｋ１９に特異的なモノクローナル抗体およびこれを産生するハイブリドーマ、癌の検出キット、癌の検出方法および癌の転移の判定方法
US10301057B2 (en) 2016-07-11 2019-05-28 Calibre Closures Llc Dispensing container with internal squeeze limiting member
CN113061184B (zh) * 2021-04-25 2022-07-01 福州迈新生物技术开发有限公司 抗ck7蛋白单克隆抗体及其细胞株、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE125626T1 (de) * 1984-01-06 1995-08-15 Univ California Cytokeratin-tumormarkierer und test zu deren nachweis.
US4727021A (en) * 1984-06-01 1988-02-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cytokeratin
DE3815932A1 (de) * 1988-01-26 1989-08-03 Progen Biotechnik Gmbh Verfahren zur identifizierung des ursprungs einer zellgewebsprobe
DE3640412A1 (de) * 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz

Also Published As

Publication number Publication date
US5288614A (en) 1994-02-22
DE3942999A1 (de) 1991-07-04
WO1991010139A1 (de) 1991-07-11
JPH082919B2 (ja) 1996-01-17
ATE120550T1 (de) 1995-04-15
DE59008810D1 (de) 1995-05-04
JPH04504063A (ja) 1992-07-23
EP0460190A1 (de) 1991-12-11
EP0460190B2 (de) 2001-11-28
CA2046888A1 (en) 1991-06-28
ES2070488T3 (es) 1995-06-01
EP0460190B1 (de) 1995-03-29
ES2070488T5 (es) 2002-07-01
DE3942999C2 (de) 1997-12-18

Similar Documents

Publication Publication Date Title
ATE120550T1 (de) Verfahren zum nachweis von malignen erkrankungen.
DK0449269T3 (da) Fremgangsmåde til påvisning af proteiner indeholdende phosphoryleret tyrosin
DE3486356D1 (de) Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.
DK0533719T3 (da) Fremgangsmåde til påvisning og/eller bestemmelse af hormoner
ATE210680T1 (de) Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
DK0811165T3 (da) Detektion af antistofproduktion
DE69128127D1 (de) NUKLEINSÄUREPROBEN mit über Hydrazin-Bindungen verbundenen negativ geladenen Haptenen
DE58909122D1 (de) Verfahren zum nachweis der funktionsfähigkeit der nierentubuli.
ATE200353T1 (de) Kompetitiver immuntest unter verwendung komplexierter analytderivate
DK414386A (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
ES2076221T3 (es) Derivados geminales de difenilo y su uso en inmunoensayos.
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
DE69610679D1 (de) Antigen für Enzymimmuntest und Verfahren zur Messung von erythrozytären Antikörpern
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
ATE112632T1 (de) Verfahren zum nachweis von leberzirrhose.
KR860007545A (ko) 인체 프로릴 4-히드록시라아제의 정량 방법
YU164090A (sh) Postopek za dokazovanje analitov
WO1990008956A1 (en) Detection of human tissue factor activator
Meager RIA, IRMA, and ELISA for cytokines and their soluble
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente